Impaired natural killer cell responses are associated with loss of the highly activated NKG2ACD57CD56 subset in HIV-1 subtype D infection in Uganda
AIDS, ISSN: 1473-5571, Vol: 28, Issue: 9, Page: 1273-1278
2014
- 16Citations
- 27Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations16
- Citation Indexes16
- 16
- CrossRef10
- Captures27
- Readers27
- 27
Article Description
Objective: Of the predominant HIV-1 subtypes in Uganda, subtype D infection confers a worse prognosis. HIV-1 infection causes perturbations to natural killer (NK) cells, and yet these cells can exert immune pressure on the virus and influence clinical outcome. Here, we studied NK cell activation and function in Ugandans with chronic untreated HIV-1 subtype D infection in comparison to uninfected community matched controls. Methods: Cryopreserved peripheral blood mononuclear cells (PBMCs) from 42 HIVinfected individuals and 28 HIV-negative controls were analysed using eight-colour flow cytometry. NK cell surface expression of CD16, CD56, CD57, HLA-DR and NKG2A were used to investigate activation, maturation and differentiation status. NK cell function was evaluated by measuring interferon-gamma (IFNg) production in response to K562 cells, or interleukin (IL)-12 and IL-18. Results: CD56 NK cells from HIV-infected individuals produced less IFNg in response to IL-12 and IL-18 than did CD56 NK cells from uninfected controls. Infected individuals had lower levels of CD56 NK cells coexpressing the differentiation markers NKG2A and CD57 than controls. In addition, their NKG2ACD57 CD56 NK cells displayed elevated activation levels as assessed by HLA-DR expression. Cytokine-induced IFNg production correlated directly with coexpression of CD57 and NKG2A on CD56 NK cells. Conclusion: HIV-1 subtype D infection is associated with impaired NK cell responsiveness to cytokines, decline of the NKG2ACD57 CD56 NK cell subset, as well as elevated activation in this subset. These alterations within the NK cell compartment may contribute to immunopathogenesis of HIV-1 subtype D infection in Ugandans.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84922481222&origin=inward; http://dx.doi.org/10.1097/qad.0000000000000286; http://www.ncbi.nlm.nih.gov/pubmed/24959961; https://journals.lww.com/00002030-201406010-00004; http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00002030-201406010-00004; http://dx.doi.org/10.1097/QAD.0000000000000286; https://dx.doi.org/10.1097/QAD.0000000000000286; https://insights.ovid.com/article/00002030-201406010-00004
Ovid Technologies (Wolters Kluwer Health)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know